These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27500301)

  • 41. Pregnancy-Related Venous Thromboembolism.
    Armstrong EM; Bellone JM; Hornsby LB; Treadway S; Phillippe HM
    J Pharm Pract; 2014 Jun; 27(3):243-52. PubMed ID: 24742932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venous Thromboembolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in the Arabian Gulf.
    Alsayegh F; Al-Jassar W; Wani S; Tahlak M; Albahar A; Al Kharusi L; Al-Tamimi H; El-Taher F; Mahmood N; Al-Zakwani I
    Curr Vasc Pharmacol; 2016; 14(4):368-73. PubMed ID: 26517701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pregnancy-associated venous thromboembolism: prevention and treatment.
    Bates SM
    Semin Hematol; 2011 Oct; 48(4):271-84. PubMed ID: 22000093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Approach to Peripartum Management of Anticoagulation: A Multidisciplinary Survey.
    Rohailla S; Malinowski AK; Gandhi S; McLeod A; Nisenbaum R; Shehata N
    J Obstet Gynaecol Can; 2018 Jul; 40(7):888-895.e6. PubMed ID: 29709455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Venous thromboembolism in pregnancy: diagnosis, management and prevention.
    Chunilal SD; Bates SM
    Thromb Haemost; 2009 Mar; 101(3):428-38. PubMed ID: 19277402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.
    Greer IA; Nelson-Piercy C
    Blood; 2005 Jul; 106(2):401-7. PubMed ID: 15811953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
    Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
    Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation.
    Skeith L
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):559-569. PubMed ID: 34889418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prophylaxis of recurrence during transient risk in patients with previous venous thromboembolism].
    Schmidt B; Schellong S
    Med Klin (Munich); 2003 Aug; 98(8):447-52. PubMed ID: 12928810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
    Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
    BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study.
    Blondon M; Lansiaux M; Bryan S; Dongala A; Pavoncello R; Chatellier G; Claver M; Azria E; Martinez de Tejada B; Hugon-Rodin J
    J Thromb Haemost; 2024 Oct; 22(10):2834-2843. PubMed ID: 38972385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy.
    Knol HM; Schultinge L; Veeger NJ; Kluin-Nelemans HC; Erwich JJ; Meijer K
    Thromb Res; 2012 Sep; 130(3):334-8. PubMed ID: 22475315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
    Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
    J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low molecular weight heparins: a guide to their optimum use in pregnancy.
    Laurent P; Dussarat GV; Bonal J; Jego C; Talard P; Bouchiat C; Cellarier G
    Drugs; 2002; 62(3):463-77. PubMed ID: 11827560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Venous thromboembolism and pregnancy].
    Horellou MH; Plu-Bureau G; Lepercq J
    Rev Med Interne; 2015 Mar; 36(3):219-24. PubMed ID: 25475826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Bates SM; Greer IA; Hirsh J; Ginsberg JS
    Chest; 2004 Sep; 126(3 Suppl):627S-644S. PubMed ID: 15383488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey.
    Voke J; Keidan J; Pavord S; Spencer NH; Hunt BJ;
    Br J Haematol; 2007 Nov; 139(4):545-58. PubMed ID: 17916101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.